Ignite Creation Date:
2025-12-25 @ 4:25 AM
Ignite Modification Date:
2026-03-09 @ 12:53 AM
Study NCT ID:
NCT02241720
Status:
TERMINATED
Last Update Posted:
2018-01-11
First Post:
2013-11-21
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Regorafenib Second Line Treatment of Metastatic or Advanced Upper GI Cancers
Sponsor:
University of Utah
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-05
Start Date Type:
None
Primary Completion Date:
2016-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-09
Completion Date Type:
ACTUAL
First Submit Date:
2013-11-21
First Submit QC Date:
None
Study First Post Date:
2014-09-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-08-04
Results First Submit QC Date:
None
Results First Post Date:
2017-10-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-12-11
Last Update Post Date:
2018-01-11
Last Update Post Date Type:
ACTUAL